Commercially Available Food Bar
Dietary SupplementOther names: Fitjoy Bar
NCT Number: NCT03166514
The purpose of this study is to examine the glucose and insulin response to a food bar.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Fitjoy is a commercially available food bar marketed as having a low glycemic index and being relatively high in dietary fiber. The fiber contained within this product is isomalto-oligoshaccaride (IMO) which is a food ingredient with a relative sweetness level equal to approximately 60% of sucrose. Chemically, IMO is a mixture of glucose oligomers with alpha - (1-6) - linkages. To date, no research has been performed on the glycemic response to ingesting IMO in combination with other constituents. Therefore the purpose of this study is to determine the glycemic index of the Fitjoy bar.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Fitjoy Bar
Other names: Dextrose Placebo
Time frame: One day
Measured in mmol/L
Time frame: One day
Measured in U/mL
Time frame: One day
Subjective questionnaire
Time frame: One day
Subjective questionnaire
Time frame: One day
Subjective questionnaire
Time frame: One day
Subjective questionnaire
Time frame: One day
Subjective questionnaire
Texas A&M University
Other
Pharmacokinetic and Glycemic Response of a Commercially Available Food Bar
Acronym: NB16
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07194772
Glucose Homeostasis, Glucose Intolerance
Ottawa, Ontario, Canada
View Trial Details